Ellen Hope Filvaroff

Title: Ellen Hope Filvaroff: Innovator in Cancer Treatment

Introduction

Ellen Hope Filvaroff is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions.

Latest Patents

Ellen holds 2 patents that focus on groundbreaking methods for treating cancer. Her latest patents include "BET inhibitors as a treatment for myelofibrosis," which provides methods, pharmaceutical compositions, and kits for treating cancer in patients. This patent outlines the administration of a BET (bromodomain and extra-terminal protein) inhibitor, either alone or in combination with JAK inhibitors, to patients in need. Another notable patent is related to "Methods of treating prostate cancer," which discusses the use of a substituted tricyclic derivative as a bromodomain inhibitor for treating prostate cancer.

Career Highlights

Ellen is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research in oncology. Her work has been instrumental in developing new therapeutic strategies for cancer patients.

Collaborations

Ellen has collaborated with notable colleagues, including Ida Aronchik and Roxxana Valeria Beltran Valencia, contributing to a dynamic research environment focused on innovative cancer treatments.

Conclusion

Ellen Hope Filvaroff's contributions to cancer treatment through her patents and research at Bristol-Myers Squibb Company highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for new therapeutic options for patients battling cancer.